Drug maker Dr Reddy’s Laboratories was looking out for partnerships to expand its presence in Japan, according to its Managing Director and COO Mr Satish Reddy. Japan is a good market and the company is looking for more presence in the generic drugs segment.
Currently the company has a small presence in Japan through its Active Pharmaceutical Ingredients (API) business. Recently, the Hyderabad-based Dr Reddy’s Laboratories (DRL) was reported to be exploring the option of stake sale to multinationals.
crackcrack| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1933.10 |
| Dr. Reddys Labs. | 1210.85 |
| Cipla | 1418.40 |
| Lupin | 2442.10 |
| Zydus Lifesciences | 1142.75 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: